Metraipolis › archive › dc_994d33ce7567
PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with… — Europe PMC PMID:41827393
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41827393
- DOI
- 10.3390/jcm15051976
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T03:14:43.796Z
- SHA-256 of the archived text
e6a7acbac5f9841552243eeb742096c8b44f92227eacdce8cc9b82a981df0b33- Stable URL of this page
https://metraipolis.com/documento/dc_994d33ce7567
How to cite
PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with… — Europe PMC PMID:41827393 — Europe PMC (en), https://europepmc.org/article/MED/41827393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_994d33ce7567 (Metraipolis archive dc_994d33ce7567, sha256 e6a7acbac5f9841552243eeb742096c8b44f92227eacdce8cc9b82a981df0b33)
BibTeX
@misc{dc994d33ce7567,
title = {PRIME-Teen-Treatment Persistence and Outcomes Associated with CGRP Monoclonal Antibodies Compared with Conventional Oral Preventives in Adolescents with… — Europe PMC PMID:41827393},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41827393},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_994d33ce7567; sha256 e6a7acbac5f9841552243eeb742096c8b44f92227eacdce8cc9b82a981df0b33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827393. Agents can read the archived copy with the MCP tool read_document.